Latest news, Events and Press Releases

Find all of our recent press releases, stay updated with the latest news and be informed about upcoming events where Curium will be attending.

Please direct any media inquiries to communications@curiumpharma.com

News Press releases Events Publications

Curium receives positive CHMP opinion of PYLCLARI® for primary staging of patients with high-risk PCa prior to initial curative therapy and to localize recurrence of PCa in patients with a suspected recurrence based on increasing serum Prostate-Specific Antigen (PSA) levels after primary treatment with curative intent

26th May 2023

Curium announces last patient enrolled in their Phase 1/2 SOLAR clinical trial imaging men with histologically-proven metastatic prostate cancer using copper Cu 64 PSMA I&T

23rd May 2023

Curasight and Curium announce global partnership for uTRACE® in prostate cancer

2nd May 2023

Curium confirms no supply challenges in North America and Europe for its ECLIPSE Phase 3 clinical trial

14th March 2023

Innovation and growing demand for nuclear medicine drives Curium expansion and 10-year commitment to St. Louis, MO

2nd March 2023

Curium’s 14 million patients to benefit from regular supply of Mo-99 and TC-99

21st December 2022

Curium’s Customers to benefit from Mo-99 Production restart

24th November 2022

Curium Announces New Indication for Ioflupane I 123 Injection in the U.S.

22nd November 2022

Nuclear Medicine Outlook: Proven Molybenum-99 Supply Chain Reliability and New Planned Capacity Continue to Benefit Patients

9th November 2022

NRG and Curium Sign Multi-Year Isotope Production Contract

18th August 2022

Curium Announces The Submission Of Its Marketing Authorization Application For [<sup>18</sup>F]-DCFPyL To The European Medicines Agency

27th June 2022

Curium Confirms No Supply Challenges of 177Lu-PSMA-I&T for ECLIPSE Trial

12th May 2022

1 … 5 6 7 … 10